Cargando…

Travel Burden and the Direct Medical Costs of Urologic Surgery

Background: Increased surgical volume is associated with better patient outcomes and shorter lengths of hospitalization. As a consequence, traveling to receive care from a high volume provider may be associated with better outcomes. However, travel may also be associated with a decision by the healt...

Descripción completa

Detalles Bibliográficos
Autores principales: Olson, Daniel J., Gore, John L., Daratha, Kenn B., Roberts, Kenneth P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341619/
https://www.ncbi.nlm.nih.gov/pubmed/34414247
http://dx.doi.org/10.36469/9825
_version_ 1783733951154618368
author Olson, Daniel J.
Gore, John L.
Daratha, Kenn B.
Roberts, Kenneth P.
author_facet Olson, Daniel J.
Gore, John L.
Daratha, Kenn B.
Roberts, Kenneth P.
author_sort Olson, Daniel J.
collection PubMed
description Background: Increased surgical volume is associated with better patient outcomes and shorter lengths of hospitalization. As a consequence, traveling to receive care from a high volume provider may be associated with better outcomes. However, travel may also be associated with a decision by the healthcare provider to increase the length of stay due to a decreased ability to return to the primary hospital should complications arise. Thus, research is needed to understand the relationship between the distance a patient must travel and their outcomes following urologic surgery. Objective: The purpose of this study was to determine whether the distance a patient travels to receive urologic surgery is associated with their length of hospital stay and direct medical hospitalization costs. Methods: This was a retrospective observational cohort study of 12 106 patients over 50 years of age undergoing transurethral resection of the prostate (TURP), radical prostatectomy (RP) or radical cystectomy (RC) in Washington State hospitals between 2009 and 2013. Distance traveled was determined by calculating the linear distance between zip code centroids of patient residence and the hospital performing their procedure. Patients were sorted into four groups classified by distance traveled (≤5 miles, 6-20 miles, 21-50 miles and ≥51 miles) and cost calculated using a charges-to-reimbursement ratio for each hospital. Statistical significance was determined using a Kruskal-Wallis test. Results: Patients traveling greater distances had significantly lower median medical costs compared with patients who lived closer to the hospitals where they underwent TURP and RP (TURP: ≤5 miles, $6243 and ≥51 miles, $5105, p≤0.001; RP: ≤5 miles, $12 407 and ≥51 miles, $11 882, p≤0.001), whereas there was no significant difference for patients undergoing RC (≤5 miles, $27 554 and ≥51 miles, $26 761, p=0.17). Likewise, patients traveling greater distances had significantly lower median lengths of hospitalization for TURP and RP (TURP: p≤0.001, RP: p≤0.001), while there was no difference for RC (p=0.50). Conclusions: Patient travel burden does appear to play a role in cost and length of hospital stay for select urologic procedures with variable levels of morbidity and recovery time. Although these findings are statistically significant, the magnitude of the effect is small.
format Online
Article
Text
id pubmed-8341619
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Columbia Data Analytics, LLC
record_format MEDLINE/PubMed
spelling pubmed-83416192021-08-18 Travel Burden and the Direct Medical Costs of Urologic Surgery Olson, Daniel J. Gore, John L. Daratha, Kenn B. Roberts, Kenneth P. J Health Econ Outcomes Res Urological/Gynecological Diseases Background: Increased surgical volume is associated with better patient outcomes and shorter lengths of hospitalization. As a consequence, traveling to receive care from a high volume provider may be associated with better outcomes. However, travel may also be associated with a decision by the healthcare provider to increase the length of stay due to a decreased ability to return to the primary hospital should complications arise. Thus, research is needed to understand the relationship between the distance a patient must travel and their outcomes following urologic surgery. Objective: The purpose of this study was to determine whether the distance a patient travels to receive urologic surgery is associated with their length of hospital stay and direct medical hospitalization costs. Methods: This was a retrospective observational cohort study of 12 106 patients over 50 years of age undergoing transurethral resection of the prostate (TURP), radical prostatectomy (RP) or radical cystectomy (RC) in Washington State hospitals between 2009 and 2013. Distance traveled was determined by calculating the linear distance between zip code centroids of patient residence and the hospital performing their procedure. Patients were sorted into four groups classified by distance traveled (≤5 miles, 6-20 miles, 21-50 miles and ≥51 miles) and cost calculated using a charges-to-reimbursement ratio for each hospital. Statistical significance was determined using a Kruskal-Wallis test. Results: Patients traveling greater distances had significantly lower median medical costs compared with patients who lived closer to the hospitals where they underwent TURP and RP (TURP: ≤5 miles, $6243 and ≥51 miles, $5105, p≤0.001; RP: ≤5 miles, $12 407 and ≥51 miles, $11 882, p≤0.001), whereas there was no significant difference for patients undergoing RC (≤5 miles, $27 554 and ≥51 miles, $26 761, p=0.17). Likewise, patients traveling greater distances had significantly lower median lengths of hospitalization for TURP and RP (TURP: p≤0.001, RP: p≤0.001), while there was no difference for RC (p=0.50). Conclusions: Patient travel burden does appear to play a role in cost and length of hospital stay for select urologic procedures with variable levels of morbidity and recovery time. Although these findings are statistically significant, the magnitude of the effect is small. Columbia Data Analytics, LLC 2016-02-03 /pmc/articles/PMC8341619/ /pubmed/34414247 http://dx.doi.org/10.36469/9825 Text en https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (4.0) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Urological/Gynecological Diseases
Olson, Daniel J.
Gore, John L.
Daratha, Kenn B.
Roberts, Kenneth P.
Travel Burden and the Direct Medical Costs of Urologic Surgery
title Travel Burden and the Direct Medical Costs of Urologic Surgery
title_full Travel Burden and the Direct Medical Costs of Urologic Surgery
title_fullStr Travel Burden and the Direct Medical Costs of Urologic Surgery
title_full_unstemmed Travel Burden and the Direct Medical Costs of Urologic Surgery
title_short Travel Burden and the Direct Medical Costs of Urologic Surgery
title_sort travel burden and the direct medical costs of urologic surgery
topic Urological/Gynecological Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341619/
https://www.ncbi.nlm.nih.gov/pubmed/34414247
http://dx.doi.org/10.36469/9825
work_keys_str_mv AT olsondanielj travelburdenandthedirectmedicalcostsofurologicsurgery
AT gorejohnl travelburdenandthedirectmedicalcostsofurologicsurgery
AT darathakennb travelburdenandthedirectmedicalcostsofurologicsurgery
AT robertskennethp travelburdenandthedirectmedicalcostsofurologicsurgery